Patent Yard Sign in
Canadian application, no grantCanada

Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

CA 2270055 A1 · Owner: Jacobsen, Poul · Inventors: Jacobsen, Poul; Kanstrup, Anders; Bury, Paul Stanley

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention relates to therapeutically active compounds of formula (I), a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 28, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 28, 2017.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 28, 2019.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 28, 1997
GrantedNo grant recorded
Term endedOctober 28, 2017
Patent numberCA 2270055 A1
Classification (IPC)C07D311/74 +2 more

Timeline

Timeline From CIPO dates

1998200020022004200620082010201220142016Application filedOct 28, 1997Term endedOct 28, 2017

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.